Stay updated on BGB324 with Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the BGB324 with Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BGB324 with Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    - Revision metadata updated: added Revision: v3.4.3. The Melanoma label and the MedlinePlus Genetics topic were removed, and Revision: v3.4.2 was deleted.
    Difference
    0.2%
    Check dated 2026-03-11T18:12:33.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Melanoma as a related topic and MedlinePlus Genetics as a related topic on the page.
    Difference
    0.2%
    Check dated 2026-03-04T14:20:51.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added related topics Melanoma and MedlinePlus Genetics to the study page.
    Difference
    0.2%
    Check dated 2026-02-25T10:42:41.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Melanoma and MedlinePlus Genetics were removed from the related topics section on the page.
    Difference
    0.2%
    Check dated 2026-02-18T06:53:21.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page updated to Revision: v3.4.2 and removed the prior notices including the lapsed funding notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T09:26:28.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Site-wide notice about government funding and NIH operating status was added, and the page version was updated from 3.4.0 to 3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:26:32.000Z thumbnail image

Stay in the know with updates to BGB324 with Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BGB324 with Pembrolizumab in Melanoma Clinical Trial page.